Cardiac mitochondrial compromise in 1-yr-old Erythrocebus patas monkeys perinatally- exposed to nucleoside reverse transcriptase inhibitors

Author： Divi Rao Leonard Sarah Kuo Maryanne Walker Brettania Orozco Christine St. Claire Marisa Nagashima Kunio Harbaugh Steven Harbaugh Jeffrey Thamire Chandrasekhar Sable Craig Poirier Miriam

Publisher： Humana Press, Inc

ISSN： 1530-7905

Source： Cardiovascular Toxicology, Vol.5, Iss.3, 2005-09, pp. : 333-346

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Naringin Ameliorates HIV-1 Nucleoside Reverse Transcriptase Inhibitors- Induced Mitochondrial Toxicity

Current HIV Research, Vol. 14, Iss. 6, 2016-12 ,pp. : 506-516

Bentham Science Publishers

Access to resources Recommend Favorite

Direct, DNA Pol-γ-Independent Effects of Nucleoside Reverse Transcriptase Inhibitors on Mitochondrial Bioenergetics

By Lund Kaleb C. Wallace Kendall B.

Cardiovascular Toxicology, Vol. 4, Iss. 3, 2004-08 ,pp. : 217-228

Humana Press, Inc

Access to resources Recommend Favorite

The Use of Nucleoside Reverse Transcriptase Inhibitors Sparing Regimens in Treatment-Experienced HIV-1 Infected Patients

Current HIV Research, Vol. 11, Iss. 3, 2013-04 ,pp. : 179-186

Bentham Science Publishers

Access to resources Recommend Favorite

Reverse Transcriptase Inhibitors as Microbicides

Current HIV Research, Vol. 10, Iss. 1, 2012-01 ,pp. : 27-35

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetics of 400 mg of raltegravir once daily in combination with atazanavir/ritonavir plus two nucleoside/nucleotide reverse transcriptase inhibitors

By Calcagno A. Tettoni M. C. Simiele M. Trentini L. Montrucchio C. D'Avolio A. Di Perri G. Bonora S.

Journal of Antimicrobial Chemotherapy, Vol. 68, Iss. 2, 2013-02 ,pp. : 482-484

Oxford University Press

Access to resources Recommend Favorite